USP <711> dissolution testing helps pharmaceutical manufacturers understand the efficacy of different pharmaceutical product dosage forms by providing insight into the dissolution rate. USP <711> testing provides critical knowledge that helps manufacturers make decisions about drug delivery methods based on data collected about effectiveness in different forms.
USP General Chapter 711 defines six different apparatus testing methods for pharmaceuticals. BA Sciences provides expertise in each method, including multiple Dissolution Apparatus IV options. We also feature HPLC (high-performance laser chromatography) systems as a testing option.
We offer USP <711> dissolution test services for each of the six apparatus methods:
- USP Dissolution Apparatus I – Basket
- USP Dissolution Apparatus II – Paddle
- USP Dissolution Apparatus III – Reciprocating Cylinder
- USP Dissolution Apparatus IV – Flow-Through Cell
- USP Dissolution Apparatus V – Paddle over Disk
- USP Dissolution Apparatus VI – Reciprocating Holder Apparatus
In keeping with USP dissolution Chapter 711 guidelines, a standard dosage, or article, for each test is defined as one tablet or capsule, or a specified standard amount. Below, we will briefly describe the core principles of each USP <711> testing method in which we offer expertise and services.